The primary activity of the contract will be the virological evaluation of therapies/strategies, alone and in combination, including (i) antiviral agents (drugs and biologics), (ii) immune-based therapies, (iii) novel gene-based therapies and (iv) transmission inhibitors in specialized assays. A secondary activity will be the production of standardized reagents (e.g., panel of drug resistant virus variants) generated during the course of these studies.

Project Start
1995-09-05
Project End
2000-09-04
Budget Start
1997-06-30
Budget End
1999-09-04
Support Year
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Southern Research Institute
Department
Type
DUNS #
006900526
City
Birmingham
State
AL
Country
United States
Zip Code
35205